{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:38:04Z","timestamp":1768689484771,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1023\/a:1017589301855","type":"journal-article","created":{"date-parts":[[2002,12,29]],"date-time":"2002-12-29T17:59:26Z","timestamp":1041184766000},"page":"63-72","source":"Crossref","is-referenced-by-count":46,"title":["Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication"],"prefix":"10.1007","volume":"102","author":[{"given":"Vesna","family":"Ponjavic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten","family":"Andr\u00e9asson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"336443_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997; 314: 180\u20131.","journal-title":"Br Med J"},{"key":"336443_CR2","first-page":"1694","volume":"314","author":"JT Backstr\u00f6m","year":"1997","unstructured":"Backstr\u00f6m JT, Hinke RL, Flicker MR. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997; 314: 1694\u20135.","journal-title":"Br Med J"},{"key":"336443_CR3","first-page":"1694","volume":"314","author":"N Blackwell","year":"1997","unstructured":"Blackwell N, Hayllar J, Kelly G. Severe persistent visual field constriction associated with vigabatrin (letter). Br Med J 1997; 314: 1694.","journal-title":"Br Med J"},{"key":"336443_CR4","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/bmj.314.7087.1130","volume":"314","author":"GA Harding","year":"1997","unstructured":"Harding GA. Severe persistent visual field constriction associated with vigabatrin (letter). Br Med J 1997; 314: 1694.","journal-title":"Br Med J"},{"key":"336443_CR5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.314.7095.1693a","volume":"314","author":"EA Wilson","year":"1997","unstructured":"Wilson EA, Brodie MJ. Severe persistent visual field constriction associated with vigabatrin (letter). Br Med J 1997; 314: 1693.","journal-title":"Br Med J"},{"key":"336443_CR6","first-page":"1694","volume":"314","author":"ICK Wong","year":"1997","unstructured":"Wong ICK, Mawer GE, Sander JWAS. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997; 314: 1694\u20135.","journal-title":"Br Med J"},{"key":"336443_CR7","first-page":"16","volume":"61","author":"EJ Hammond","year":"1988","unstructured":"Hammond EJ, Rangel RJ, Wilder BJ. Evoked potential monitoring of vigabatrin patients. Br J Clin Pract 1988; 61: 16\u201323.","journal-title":"Br J Clin Pract"},{"key":"336443_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2125.1989.tb03463.x","volume":"27","author":"V Cosi","year":"1989","unstructured":"Cosi V, Callieco R, Galimberti CA, Manni R, Tartara A, Mumford J, Perucca E. Effects of vigabatrin on evoked potentials in epileptic patients. Br J Clin Pharmac 1989; 27: 68.","journal-title":"Br J Clin Pharmac"},{"key":"336443_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1528-1157.1989.tb05829.x","volume":"30","author":"C Liegeois-Chauvel","year":"1989","unstructured":"Liegeois-Chauvel C, Marquis F, Gisselbrecht D, Pantieri R, Beumont D, Chauvel P. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients. Epilepsia 1989; 30: 23\u20135.","journal-title":"Epilepsia"},{"key":"336443_CR10","first-page":"34","volume":"29","author":"J Steinhoff","year":"1997","unstructured":"Steinhoff J, Freudenthaler N, Paulus W. The influence of established and new epileptic drugs on visual perception. Epilepsy Res 1997; 29: 34\u201347.","journal-title":"Epilepsy Res"},{"key":"336443_CR11","first-page":"973","volume":"39","author":"T Duckett","year":"1998","unstructured":"Duckett T, Brigell MG, Ruckh S. Electroretinographic changes are not associated with loss of visual function in paediatric epileptic patients following treatment with vigabatrin. Invest Ophthalmol Vis Sci 1998; 39: 973.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"336443_CR12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","volume":"50","author":"GL Krauss","year":"1998","unstructured":"Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998; 50: 614\u20138.","journal-title":"Neurology"},{"key":"336443_CR13","first-page":"817","volume":"116","author":"K Ruether","year":"1998","unstructured":"Ruether K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M. Electrophysiologic evaluation of a patient with peripheral visual field constriction associated with vigabatrin. Arch Ophthalmol 1998; 116: 817\u20139.","journal-title":"Arch Ophthalmol"},{"key":"336443_CR14","first-page":"233","volume":"316","author":"R Mackenzie","year":"1998","unstructured":"Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. Br Med J 1998; 316: 233.","journal-title":"Br Med J"},{"key":"336443_CR15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp.67.6.716","volume":"67","author":"MC Lawden","year":"1999","unstructured":"Lawden MC, Eke T, Degg C, Harding GF, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999; 67: 716\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"336443_CR16","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","volume":"106","author":"H Daneshvar","year":"1999","unstructured":"Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 1999; 106: 1792\u20138.","journal-title":"Ophthalmology"},{"key":"336443_CR17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0002-9394(14)71649-6","volume":"124","author":"S Andr\u00e9asson","year":"1997","unstructured":"Andr\u00e9asson S, Ponjavic V, Abrahamson M, et al. Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene. Am J Ophthalmol 1997; 124: 95\u2013102.","journal-title":"Am J Ophthalmol"},{"key":"336443_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6989(92)90235-B","volume":"32","author":"EE Sutter","year":"1992","unstructured":"Sutter EE, Tran D. The field topography of ERG components in man, I: the photopic luminance response. Vision Res 1992; 32: 433\u201346.","journal-title":"Vision Res"},{"key":"336443_CR19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1364\/JOSAA.13.000634","volume":"13","author":"MA Bearse","year":"1996","unstructured":"Bearse MA, Sutter EE. Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A 1996; 13: 634\u201340.","journal-title":"J Opt Soc Am A"},{"issue":"5","key":"336443_CR20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0161-6420(00)00077-4","volume":"107","author":"I Nousiainen","year":"2000","unstructured":"Nousiainen I, K\u00e4lvi\u00e4inen R, M\u00e4ntyj\u00e4rvi M. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. Ophthalmology 2000; 107(5): 884\u20138.","journal-title":"Ophthalmology"},{"key":"336443_CR21","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1212\/WNL.53.9.2082","volume":"53","author":"NL Miller","year":"1999","unstructured":"Miller NL, Johnson MA, Paul SR, et al. Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology 1999; 53: 2082\u20137.","journal-title":"Neurology"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017589301855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1017589301855\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017589301855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:15:50Z","timestamp":1753762550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1017589301855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["336443"],"URL":"https:\/\/doi.org\/10.1023\/a:1017589301855","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}